[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fBbMryEZylCA-0kqMGYS1NSQvgV4L_GECpPdiP3GGTIM":8,"$fWHHkLa5b7A4op7urL-5Udmji2olL4XvfZov3GHsThhw":55,"$faGvE409YLdJPFO59ljYpa8GO-i9Q_uCX19YmXQZl2ww":58},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},67359,867292,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//Rz3tpGmxUSBrZZI9JGKnUVlnkQTc1HPm.png","郭峰","聊城市第二人民医院","甲状腺乳腺外科","副主任医师",10,0,"乳腺癌早期治疗常用化疗药物安全用药指南","","https://ystcdn.venuertc.com/venue/AI/b52f25f0-4b99-443b-b564-09db772eedff.jpg","\u003Cdiv class=\"bc_material_wrap\">\n  \u003Ch2 id=\"material_title\" class=\"bc_material_title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">乳腺癌早期治疗常用化疗药物安全用药指南\u003C/h2>\n  \u003Cdiv class=\"bc_material_intro\">\n    \u003Cp>说起来，化疗药物在乳腺癌早期的治疗中扮演着重要角色，尤其是在手术后预防复发方面。像多西他赛和环磷酰胺这样常用的化疗药物，它们的机制、用法、注意事项都存在不少细节。今天我们就从7个角度，详细告诉您如何安全高效地使用这类药品，确保每一步都用得放心。\u003C/p>\n  \u003C/div>\n\n  \u003C!-- 用药机制部分 -->\n  \u003Cdiv class=\"bc_material_section\" style=\"background: linear-gradient(90deg, #f3f6fb 60%, #ebeff9 100%); padding: 28px 26px; border-radius: 10px; margin-bottom: 38px;\">\n    \u003Ch2 class=\"bc_material_subtitle\" style=\"background: rgba(209, 226, 241, 0.35); border-radius: 8px; padding: 12px 18px; font-size: 1.25em; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 🧬 药物机制：多西他赛与环磷酰胺如何发挥作用？\u003C/h2>\n    \u003Cul class=\"bc_material_list\">\n      \u003Cli>\n        \u003Cb>多西他赛（Docetaxel）\u003C/b>属于紫杉类药物，通过稳定微管结构，阻止细胞分裂，这样可以有效地抑制异常细胞的增殖。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>环磷酰胺（Cyclophosphamide）\u003C/b>是一种烷化剂。它通过破坏 DNA 的结构，从源头防止细胞的复制和生长。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"bc_material_tip\">\u003Cspan style=\"color:#4C8AD5;font-weight:500;\">需要注意：\u003C/span>此类药品属于处方药，仅能在医疗机构严格管理下使用。\u003C/div>\n    \u003Cdiv class=\"bc_material_ref\">参考文献: Crown, J. et al., \"Docetaxel: current status and future prospects\", British Journal of Cancer, 2004; Emadi, A. et al., \"Cyclophosphamide and Cancer: Mechanisms of Action\", Nat Rev Clin Oncol, 2009.\u003C/div>\n  \u003C/div>\n\n  \u003C!-- 剂型与规格 -->\n  \u003Cdiv class=\"bc_material_section\" style=\"background: linear-gradient(90deg,#f6fbf3 63%, #eaf8eb 100%); padding: 28px 26px; border-radius: 10px; margin-bottom: 38px;\">\n    \u003Ch2 class=\"bc_material_subtitle\" style=\"background: rgba(209, 241, 234, 0.33); border-radius: 8px; padding: 12px 18px; font-size: 1.25em; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 💉 剂型规格与给药方式：化疗怎么用？\u003C/h2>\n    \u003Cul class=\"bc_material_list\">\n      \u003Cli>\n        多西他赛和环磷酰胺\u003Cstrong>均为注射剂\u003C/strong>，需要通过静脉输注方式给药。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>正确做法：\u003C/b>药物须由有经验的医护人员在医院内配制及输入，严禁自行在家操作。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>剂量与方案：\u003C/b>剂量按体表面积(单位mg/m\u003Csup>2\u003C/sup>)计算，常见联用方案如TC方案（多西他赛+环磷酰胺），每21天为一个疗程，通常化疗周期为4-6个疗程。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"bc_material_tip\">\u003Cspan style=\"color:#14981c;\">特别提醒：\u003C/span>剂量和疗程需由医生根据身体情况决策，擅自调整会带来风险。\u003C/div>\n    \u003Cdiv class=\"bc_material_ref\">参考文献: Jones, S.E. et al., \"Randomized comparison of docetaxel and cyclophosphamide versus doxorubicin and cyclophosphamide...\", Journal of Clinical Oncology, 2005.\u003C/div>\n  \u003C/div>\n\n  \u003C!-- 用药时间与操作细节 -->\n  \u003Cdiv class=\"bc_material_section\" style=\"background: linear-gradient(90deg,#fcfbf3 65%, #fbf7ea 100%); padding: 28px 26px; border-radius: 10px; margin-bottom: 38px;\">\n    \u003Ch2 class=\"bc_material_subtitle\" style=\"background: rgba(241, 237, 209, 0.35); border-radius: 8px; padding: 12px 18px; font-size: 1.25em; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 ⏰ 给药时机与操作细节\u003C/h2>\n    \u003Cul class=\"bc_material_list\">\n      \u003Cli>\n        \u003Cb>给药时间：\u003C/b>多西他赛30-60分钟内输注，环磷酰胺30-90分钟内缓慢输入，顺序一般无严格要求，但必须分开静脉滴注。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>支持用药：\u003C/b>化疗当天建议准备止吐药（如昂丹司琼）和补液，医生会根据方案联合使用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>操作要点：\u003C/b>每次输液前需评估静脉状态，避免外渗；用药过程中应密切观察反应。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"bc_material_tip\">正确做法：全程遵医嘱完成输液，不要自行变更速率。任何异常感受（如局部肿痛）要立刻告知医护人员。\u003C/div>\n    \u003Cdiv class=\"bc_material_case\">📝 临床用药案例：一位59岁女士完成两次TC方案化疗期间，按照输注时间与速率要求执行，未出现不良反应，顺利完成疗程。\u003C/div>\n    \u003Cdiv class=\"bc_material_ref\" style=\"margin-top:4px;\">参考文献: Slamon, D.J. et al., \"Use of Chemotherapeutic Agents in the Adjuvant Setting\", New England Journal of Medicine, 2015.\u003C/div>\n  \u003C/div>\n\n  \u003C!-- 药物相互作用 -->\n  \u003Cdiv class=\"bc_material_section\" style=\"background: linear-gradient(90deg,#f3fbf6 63%, #eafbf8 100%); padding: 28px 26px; border-radius: 10px; margin-bottom: 38px;\">\n    \u003Ch2 class=\"bc_material_subtitle\" style=\"background: rgba(209, 241, 234, 0.28); border-radius: 8px; padding: 12px 18px; font-size: 1.25em; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 ⚠️ 药物相互作用有哪些？\u003C/h2>\n    \u003Cul class=\"bc_material_list\">\n      \u003Cli>\n        \u003Cb>多西他赛：\u003C/b>\n        \u003Cul>\n          \u003Cli>避免同时服用强CYP3A4抑制剂（如酮康唑、红霉素），否则会增加其体内浓度，提高毒性风险。\u003C/li>\n          \u003Cli>应注意华法林、卡马西平等药物与其同用可能影响药物代谢。\u003C/li>\n        \u003C/ul>\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>环磷酰胺：\u003C/b>\n        \u003Cul>\n          \u003Cli>肝酶诱导剂（例如苯妥英钠、利福平）可加快其代谢，降低药效。\u003C/li>\n          \u003Cli>可与部分免疫抑制剂或其他化疗药发生协同或拮抗作用。\u003C/li>\n        \u003C/ul>\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"bc_material_tip\">\u003Cspan style=\"color:#4C8AD5;\">特别提醒：\u003C/span>使用期间务必告知医生所有正在服用的处方、非处方药，包括中草药。\u003C/div>\n    \u003Cdiv class=\"bc_material_ref\">参考文献: van den Brink, W. et al., \"Pharmacokinetic interactions of antineoplastic drugs\", Cancer Treatment Reviews, 2006.\u003C/div>\n  \u003C/div>\n\n  \u003C!-- 特殊人群用药要点 -->\n  \u003Cdiv class=\"bc_material_section\" style=\"background: linear-gradient(90deg,#fbf3fa 75%, #f8eafb 100%); padding: 28px 26px; border-radius: 10px; margin-bottom: 38px;\">\n    \u003Ch2 class=\"bc_material_subtitle\" style=\"background: rgba(241, 209, 241, 0.3); border-radius: 8px; padding: 12px 18px; font-size: 1.25em; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 👨‍🦳 特殊人群用药调整\u003C/h2>\n    \u003Cul class=\"bc_material_list\">\n      \u003Cli>\n        \u003Cb>老年人：\u003C/b>常规剂量基础上需评估肝肾功能，部分患者可能需要下调剂量，严防骨髓抑制。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>肝肾功能异常：\u003C/b>肝功能不好时，多西他赛用量需谨慎，环磷酰胺亦需评估排泄情况。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>孕妇与哺乳期：\u003C/b>化疗药物能影响胎儿和乳汁分泌，须在医生充分评估下权衡利弊。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"bc_material_tip\">正确做法：用药前做全面评估，按医嘱调整个体剂量，避免自行增减。\u003C/div>\n    \u003Cdiv class=\"bc_material_ref\">参考文献: Extermann, M. et al., \"Chemotherapy for older patients\", Cancer Control, 2003; Loibl, S. et al., \"Safety of systemic therapy in pregnancy...\", Breast Cancer Research, 2003.\u003C/div>\n  \u003C/div>\n\n  \u003C!-- 不良反应与处理 -->\n  \u003Cdiv class=\"bc_material_section\" style=\"background: linear-gradient(90deg,#fbeefb 65%, #fde4fd 100%); padding: 28px 26px; border-radius: 10px; margin-bottom: 38px;\">\n    \u003Ch2 class=\"bc_material_subtitle\" style=\"background: rgba(241, 209, 234, 0.25); border-radius: 8px; padding: 12px 18px; font-size: 1.25em; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 🚨 常见不良反应及处理方法\u003C/h2>\n    \u003Cul class=\"bc_material_list\">\n      \u003Cli>\n        \u003Cb>最常见：\u003C/b>白细胞减少、感染风险、恶心、呕吐、脱发、乏力。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>多西他赛特有：\u003C/b>下肢水肿、指甲变色、罕见过敏反应；极少数人可出现神经、心脏相关问题。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>环磷酰胺相关：\u003C/b>膀胱刺激感、少数人可有肝功能损害。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>严重反应如何识别与处理：\u003C/b>出现持续高热、明显出血点、持续严重恶心呕吐、意识障碍等应及时就医，不可自行用药或等待。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"bc_material_tip\">管理策略：化疗期间按周期复查血常规和肝肾功能，发生副作用要及时报告医务人员。恶心呕吐可以提前备好止吐药。\u003C/div>\n    \u003Cdiv class=\"bc_material_ref\">\n      参考文献: Nabholtz, J.-M. et al., \"Docetaxel in the treatment of breast cancer...\", The Oncologist, 2003; Glimelius, B. et al., \"Side-effects of adjuvant chemotherapy for cancer...\", Annals of Oncology, 2005.\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 存储与有效期要求 -->\n  \u003Cdiv class=\"bc_material_section\" style=\"background: linear-gradient(90deg,#e9f9fa 68%, #f5fafc 100%); padding: 28px 26px; border-radius: 10px; margin-bottom: 38px;\">\n    \u003Ch2 class=\"bc_material_subtitle\" style=\"background: rgba(209, 241, 241, 0.19); border-radius: 8px; padding: 12px 18px; font-size: 1.25em; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 🏷️ 储存方法与有效期要求\u003C/h2>\n    \u003Cul class=\"bc_material_list\">\n      \u003Cli>\n        \u003Cb>未开封：\u003C/b>多西他赛注射液存放于2-8℃冰箱，避免阳光直射；环磷酰胺贮存于干燥、阴凉处。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>开瓶后：\u003C/b>按说明书或医生要求尽快用完——通常配好后应立即使用，剩余药液禁止再次使用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>过期药品：\u003C/b>所有过期或变质药物务必按医疗废弃物处理，严禁自行丢弃或随意冲入下水道。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"bc_material_tip\">正确做法：药物全程交由专业人员储存和管理，不留“自用剩药”。\u003C/div>\n    \u003Cdiv class=\"bc_material_ref\">参考文献: Docetaxel [package insert]. Sanofi-Aventis, 2016; Cyclophosphamide [package insert]. Baxter, 2020.\u003C/div>\n  \u003C/div>\n\n  \u003C!-- 补充内容：漏服与异常情况处置 -->\n  \u003Cdiv class=\"bc_material_section\" style=\"background: linear-gradient(90deg, #fff5e6 68%, #fffaf1 100%); padding: 28px 26px; border-radius: 10px; margin-bottom: 44px;\">\n    \u003Ch2 class=\"bc_material_subtitle\" style=\"background: rgba(255, 233, 197, 0.24); border-radius: 8px; padding: 12px 18px; font-size: 1.25em; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 ❗ 漏服和过量应对\u003C/h2>\n    \u003Cul class=\"bc_material_list\">\n      \u003Cli>\n        \u003Cb>漏用：\u003C/b>静脉化疗如因故推迟，必须联系主治医生重新排期，切勿自行补用或缩短周期。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>过量：\u003C/b>一旦意外剂量过高，需立即寻求医护协助，密切监测生命体征和血常规，根据症状对症干预。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"bc_material_tip\">提示：化疗用药流程通常不会出现漏服，若发生任何流程偏差，及时与医务人员沟通，不可擅自做出决定。\u003C/div>\n    \u003Cdiv class=\"bc_material_ref\">\n      参考文献：de Jonge, M. E. et al., \"Risks and Management of Chemotherapy Overdose\", The Oncologist, 2005.\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 总结 -->\n  \u003Cdiv class=\"bc_material_conclusion\" style=\"margin: 0 0 24px 0; padding: 26px 22px; background: linear-gradient(90deg,#ebf6fc 74%, #fafcff 100%); border-radius:8px;\">\n    \u003Ch3 class=\"bc_material_conclusion_title\" style=\"font-size: 1.13em; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">结语与安全要点回顾\u003C/h3>\n    \u003Cul class=\"bc_material_list\">\n      \u003Cli>\u003Cb>多西他赛与环磷酰胺等化疗药物\u003C/b>在正规医疗环境下可以大幅提高早期乳腺癌的治愈概率；只要严格遵照用药流程，绝大多数患者都能顺利度过化疗周期。\u003C/li>\n      \u003Cli>需要您重点记住两件事：\u003Cb>药物必须由医疗人员操作，不能私自用药；随时关注异常症状并主动通报，多一分警觉就多一分安全。\u003C/b>\u003C/li>\n      \u003Cli>有任何用药疑问或不适，都应及时联系主治医生。\u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.bc_material_wrap {\n  font-family: 'Segoe UI', 'Microsoft YaHei', Arial, sans-serif;\n  font-size: 18px;\n  color: #223345;\n  background: #fcfcfe;\n  border-radius: 18px;\n  max-width: 880px;\n  margin: 0 auto 46px auto;\n  box-shadow: 0 4px 20px 0 rgba(50,84,147,0.08);\n  padding: 0 0 28px 0;\n  line-height: 1.94;\n}\n\n.bc_material_title {\n  font-size: 2.13em;\n  font-weight: 700;\n  margin: 0 0 34px 0;\n  padding: 32px 0 0 0;\n  color: #2866aa;\n  letter-spacing: 0.03em;\n  text-align: center;\n  background: linear-gradient(90deg,#f0f7fc 59%,#b2d4f6 100%);\n  border-radius: 18px 18px 0 0;\n}\n\n.bc_material_intro {\n  font-size: 1.12em;\n  color: #274660;\n  background: #f6faff;\n  border-radius: 0px 0px 12px 12px;\n  padding: 22px 34px 24px 34px;\n  margin: 0 0 26px 0;\n}\n\n.bc_material_section {\n  margin-bottom: 38px;\n  box-sizing: border-box;\n  border-radius: 10px;\n}\n\n.bc_material_subtitle {\n  font-weight: 600;\n  color: #385b7a;\n  margin-bottom: 16px;\n  line-height: 1.7;\n  letter-spacing: 0.01em;\n  display: inline-block;\n}\n\n.bc_material_list {\n  margin: 0 0 14px 0;\n  padding: 0 0 0 1.1em;\n  font-size: 1em;\n}\n\n.bc_material_list li {\n  margin-bottom: 1em;\n  list-style: disc;\n}\n\n.bc_material_tip {\n  color: #225a20;\n  background: #edfaf0;\n  border-left: 5px solid #41b75c;\n  border-radius: 5px;\n  margin: 16px 0 6px 0;\n  padding: 8px 16px;\n  font-size: 1em;\n}\n\n.bc_material_ref {\n  font-size: 0.96em;\n  color: #60748b;\n  background: #f2f4fd;\n  border-radius: 6px;\n  margin-top: 12px;\n  padding: 8px 14px;\n  line-height: 1.5;\n}\n.bc_material_case {\n  color:#634a21;\n  background:#fcf3ea;\n  border-left: 4px solid #e2b354;\n  border-radius: 5px;\n  padding: 8px 16px;\n  margin: 14px 0 7px 0;\n  font-size: 1em;\n}\n\n.bc_material_conclusion {\n  background: linear-gradient(90deg,#ebf6fc 74%, #fafcff 100%);\n  border-radius:8px;\n  padding: 26px 22px 18px 22px;\n  margin-top:24px;\n}\n\n.bc_material_conclusion_title {\n  font-size: 1.13em;\n  color: #2e566f;\n  font-weight: bold;\n  margin-bottom: 12px;\n}\n\n@media (max-width: 650px) {\n  .bc_material_wrap {\n    font-size: 16px;\n    padding: 0 0 10px 0;\n  }\n  .bc_material_title {\n    font-size:1.33em;\n    padding: 18px 0 10px 0;\n  }\n  .bc_material_intro {\n    padding: 14px 12px 14px 12px;\n    font-size:1em;\n  }\n  .bc_material_section {\n    padding: 18px 11px;\n  }\n  .bc_material_subtitle {\n    font-size: 1.09em;\n    padding:10px 9px;\n  }\n  .bc_material_ref,\n  .bc_material_tip,\n  .bc_material_case {\n    padding-left:8px;\n    padding-right:8px;\n    font-size:0.94em;\n  }\n}\n\u003C/style>\n\n","\u003Cdiv class=\"bc_material_wrap\">\n  \u003Ch2 id=\"material_title\" class=\"bc_material_title\" style=\"color: rgb",512,"2025-09-28 14:26:30","乳腺癌化疗, 多西他赛, 环磷酰胺, 安全用药, 化疗药物","本文详细介绍了多西他赛与环磷酰胺这两种化疗药物的安全使用策略，适用于乳腺癌患者，确保在正规医疗环境下安全有效地预防复发。","2025-10-08 15:07:19",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":20,"result":57,"totalSize":21},[],{"code":9,"msg":10,"message":6,"data":59,"success":54},{"authors":60,"appraiseDimensionScoresVos":61},[],[]]